Media Coverage

Secaucus-based Quest Diagnostics, a provider of diagnostic information services, announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. Based in Seattle, PhenoPath provides AP, molecular oncology and other services that complement and extend those of the company’s Advanced Diagnostics portfolio of services. These include services, such as genetic sequencing and genomic tumor analysis, which require higher-order expertise and skill.

Gov. Phil Murphy was thrilled to join Quest Diagnostics CEO Steve Rusckowski at a ribbon-cutting for Quest’s new headquarters in Secaucus on Thursday morning. Murphy said he hoped that other CEOs would look at Quest, a Fortune 500 company, choosing New Jersey and follow suit. “We have a newfound will, in addition to our natural assets, to use our advantages to their fullest potential,” he said. “I hope that somewhere, the CEO of another forward-looking, innovative company is listening to us and saying, ‘You know what, if New Jersey works for Quest, then I’ve got to look there, too.’” Murphy spoke of the density of the talent pool in the northern region of the state, proximity to New York City, view of the city and transportation in the area. Murphy also hinted at his upcoming economic development trips abroad.

Quest Diagnostics announced today it has acquired specialized anatomic pathology service firm PhenoPath. The deal, whose terms were not disclosed, continued a buying spree for Quest this week, which included the acquisitions of Oxford Immunotec's US lab business and fertility and fertility diagnostics services firm ReproSource. PhenoPath is based in Seattle and provides anatomic pathology, molecular oncology, and other services such as genetic sequencing and genomic tumor analysis. It will operate as part of AmeriPath, a wholly owned subsidiary of Quest.

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Regional Medical Center Health System (RMC), a regional health care provider for a five-county service area in northeast Alabama, are teaming up to enhance the quality and value of diagnostic services to patients and their doctors through a new partnership agreement under which Quest will provide supply chain expertise, as well as perform laboratory reference testing.

Since Colorado legalized marijuana, the state has become a popular destination for so-called weed tourists. Johnny Welsh, a writer and bartender in Frisco, Colorado, a Rocky Mountain town near Vail, remembers when he would have the entire fall off work. "The restaurants closed, and you could travel the world," he told MoneyWatch, somewhat wistfully. Nationwide, the rate of workers testing positive for drugs has increased over the past decade, according to Quest Diagnostics, a major drug-testing laboratory. It has also risen in states that have made the drug legal. But the rate of increase has been about the same across the two categories, said Barry Sample, Quest's senior director for science and technology.